Nektar claims phase 2 alopecia success after excluding patients who ‘should never have been enrolled’
Nektar claims phase 2 alopecia success after excluding patients who ‘should never have been enrolled’
Body unavailable. Use the original source.
Nektar claims phase 2 alopecia success after excluding patients who ‘should never have been enrolled’
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.